IP Verse

Napp Pharmaceutical competitive analysis

Latest publications and patents of Napp Pharmaceutical New

Explore the latest publications and patents granted to Napp Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Napp Pharmaceutical

EP2425824
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneRevoked
EP2425821
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneRevoked
EP1731152
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineRevoked

Latest patents of Napp Pharmaceutical opposed by its competitors

Explore Napp Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2425821
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP2425824
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
EP1731152
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3

Latest PTAB cases involving Napp Pharmaceutical

Discover the latest PTAB cases involving Napp Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Napp Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NAPP PHARMACEUTICAL - 25 - - Non-Active
ACINO PHARMA2 - - - Highly Aggressive
DEVELCO PHARMA SCHWEIZ5 - - - Highly Aggressive
ETHYPHARM112 - - Highly Aggressive